{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:15:19Z","timestamp":1785338119262,"version":"3.55.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","funder":[{"name":"Natural Science Foundation of Jiangsu Province Health Department","award":["YG201311"],"award-info":[{"award-number":["YG201311"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1097\/md.0000000000022362","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T18:04:10Z","timestamp":1600452250000},"page":"e22362","source":"Crossref","is-referenced-by-count":3,"title":["Association of cytokine gene polymorphisms with chronic hepatitis C virus genotype 1b infection in Chinese Han population"],"prefix":"10.1097","volume":"99","author":[{"given":"Ji-Sheng","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-Qun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Kui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"issue":"(Suppl 2)","key":"R1-20230103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1478-3231.2011.02537.x","article-title":"The global health burden of hepatitis C virus infection","volume":"31","author":"Negro","year":"2011","journal-title":"Liver Int"},{"key":"R2-20230103","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd","year":"2013","journal-title":"Hepatology"},{"key":"R3-20230103","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/jgh.13709","article-title":"Urgency to treat patients with chronic hepatitis C in Asia","volume":"32","author":"Kao","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"(Suppl 1)","key":"R4-20230103","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J Hepatol"},{"key":"R5-20230103","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1053\/j.gastro.2006.07.022","article-title":"Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin","volume":"131","author":"Bronowicki","year":"2006","journal-title":"Gastroenterology"},{"key":"R6-20230103","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"R7-20230103","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cyto.2012.11.003","article-title":"Cytokines genes polymorphisms in chronic hepatitis C: impact on susceptibility to infection and response to therapy","volume":"61","author":"Pasha","year":"2013","journal-title":"Cytokine"},{"key":"R8-20230103","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1086\/503436","article-title":"Association of transforming growth factor-beta 1 functional polymorphisms with natural clearance of hepatitis C virus","volume":"193","author":"Kimura","year":"2006","journal-title":"J Infect Dis"},{"key":"R9-20230103","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.humimm.2011.06.008","article-title":"Polymorphism of tumor necrosis factor-alpha and interleukin-10 gene promoter region in chronic hepatitis C virus patients and their effect on pegylated interferon-alpha therapy response","volume":"72","author":"Dogra","year":"2011","journal-title":"Hum Immunol"},{"key":"R10-20230103","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3748\/wjg.v11.i13.1929","article-title":"Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection","volume":"11","author":"Wang","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R11-20230103","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cyto.2012.05.010","article-title":"Influence of transforming growth factor-beta1 and tumor necrosis factor-alpha genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients","volume":"60","author":"Radwan","year":"2012","journal-title":"Cytokine"},{"key":"R12-20230103","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.3748\/wjg.v17.i34.3941","article-title":"Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis","volume":"17","author":"Wei","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R13-20230103","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.trim.2012.10.003","article-title":"The association between cytokine gene polymorphisms and graft rejection in liver transplantation: a systematic review and meta-analysis","volume":"28","author":"Rattanasiri","year":"2013","journal-title":"Transpl Immunol"},{"key":"R14-20230103","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.3748\/wjg.15.5610","article-title":"Polymorphisms of some cytokines and chronic hepatitis B and C virus infection","volume":"15","author":"Gao","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R15-20230103","first-page":"179","article-title":"Sofosbuvir, pegylated Interferon and Ribavirin in the treatment of an Egyptian Cohort with hepatitis C virus infection in real-life clinical practice","volume":"19","author":"Abd-Elsalam","year":"2019","journal-title":"Infect Disord Drug Targets"},{"key":"R16-20230103","first-page":"143","article-title":"Hepatitis C virus: efficacy of new DAAs regimens","volume":"20","author":"Mohamed","year":"2020","journal-title":"Infect Disord Drug Targets"},{"key":"R17-20230103","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1478-3231.2010.02283.x","article-title":"Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin","volume":"30","author":"Asselah","year":"2010","journal-title":"Liver Int"},{"key":"R18-20230103","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.3748\/wjg.v11.i42.6656","article-title":"Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3","volume":"11","author":"Abbas","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R19-20230103","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jmv.21011","article-title":"Association of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infection","volume":"80","author":"Pereira","year":"2008","journal-title":"J Med Virol"},{"key":"R20-20230103","first-page":"71","article-title":"Association of cytokine gene polymorphisms with hepatitis C virus infection in a population from Rio de Janeiro, Brazil","volume":"7","author":"Fabricio-Silva","year":"2015","journal-title":"Hepat Med"},{"key":"R21-20230103","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MD.0000000000018408","article-title":"Interleukin-6 gene polymorphisms and susceptibility to liver diseases: a meta-analysis","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine"},{"key":"R22-20230103","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jmv.10472","article-title":"Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection","volume":"71","author":"Barrett","year":"2003","journal-title":"J Med Virol"},{"key":"R23-20230103","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/JIR.S166564","article-title":"IL-1\u03b1 correlates with severity of hepatitis C virus-related liver diseases","volume":"11","author":"Tawfik","year":"2018","journal-title":"J Inflamm Res"},{"key":"R24-20230103","first-page":"38","article-title":"Patients with chronic hepatitis C receiving sofosbuvir and ribavirin-based treatment, with or without interferon in Zhejiang, China: an observational study","volume":"97","author":"Xu","year":"2018","journal-title":"Medicine"},{"key":"R25-20230103","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ebiom.2018.10.045","article-title":"Genetic influence of Toll-like receptors on non-HIV cryptococcal meningitis: an observational cohort study","volume":"37","author":"Jiang","year":"2018","journal-title":"EBioMedicine"},{"key":"R26-20230103","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.humimm.2016.10.015","article-title":"Interleukin 10 gene single nucleotide polymorphisms in Polish patients with chronic hepatitis C: Analysis of association with severity of disease and treatment outcome","volume":"78","author":"Swiatek-Koscielna","year":"2017","journal-title":"Hum Immunol"},{"key":"R27-20230103","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.gene.6363920","article-title":"Differential regulation of interleukin-10 production by genetic and environmental factors--a twin study","volume":"3","author":"Reuss","year":"2002","journal-title":"Genes Immun"},{"key":"R28-20230103","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0014-5793(00)01905-0","article-title":"IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3","volume":"480","author":"Shen","year":"2000","journal-title":"FEBS Lett"},{"key":"R29-20230103","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.humimm.2014.06.017","article-title":"Low IL10 serum levels as key factor for predicting the sustained virological response to IFNalpha\/ribavirin in Brazilian patients with HCV carrying IL28B CT\/TT genotype","volume":"75","author":"Vasconcelos","year":"2014","journal-title":"Hum Immunol"},{"key":"R30-20230103","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1440-1746.2012.07273.x","article-title":"Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon\/ribavirin-therapy","volume":"27","author":"Shaker","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R31-20230103","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S0950268814000466","article-title":"Association of interleukin-10 polymorphisms with chronic hepatitis C virus infection in a case-control study and its effect on the response to combined pegylated interferon\/ribavirin therapy","volume":"143","author":"Khan","year":"2015","journal-title":"Epidemiol Infect"},{"key":"R32-20230103","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejmhg.2013.03.006","article-title":"Serum level of interleukin-10 with its gene polymorphism can be predictors of response to treatment in Egyptian patients with chronic hepatitis C virus","volume":"14","author":"Bassat","year":"2013","journal-title":"Egypt J Med Hum Genet"},{"key":"R33-20230103","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.dld.2008.09.017","article-title":"IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients","volume":"41","author":"Chuang","year":"2009","journal-title":"Dig Liver Dis"},{"key":"R34-20230103","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cyto.2014.12.022","article-title":"Polymorphisms of IL-10 gene in patients infected with HCV under antiviral treatment in southern Brazil","volume":"73","author":"Da","year":"2015","journal-title":"Cytokine"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T21:35:00Z","timestamp":1672781700000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022362"}},"subtitle":["An observational study"],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":34,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022362","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]}}}